LEADER 01384nam  2200445   450 
001 9910583463603321
010   $a0-12-812249-8
010   $a0-12-812218-8
035   $a(CKB)4100000003350329
035   $a(MiAaPQ)EBC5357878
035   $a(PPN)230623735
035   $a(EXLCZ)994100000003350329
100   $a20180520d2018      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNanotechnology-based targeted drug delivery systems for brain tumors /$fedited by Prashant Kesharwani, Umesh Gupta
210  1$aLondon :$cAcademic Press, an imprint of Elsevier,$d[2018]
210  4$dİ2018
215   $a1 online resource (602 pages)
606   $aBlood-brain barrier$xEffect of drugs on
606   $aNanotechnology
606   $aDrug development
606   $aBrain$xCancer$xTreatment
615  0$aBlood-brain barrier$xEffect of drugs on.
615  0$aNanotechnology.
615  0$aDrug development.
615  0$aBrain$xCancer$xTreatment.
676   $a615.78
702   $aGupta$b Umesh
702   $aKesharwani$b Prashant
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910583463603321
996   $aNanotechnology-based targeted drug delivery systems for brain tumors$92288497
997   $aUNINA